Related Experiment Video
Updated: May 23, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA
Jaehoon Lee1, Jianhua Zhou, Xuexiu Zheng
1School of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea.
Abstract:
Alternative splicing plays an important role in the control of apoptosis. A number of genes related to apoptosis undergo alternative splicing. Among them, the apoptotic regulator Bcl-x produces two major isoforms, Bcl-xL and Bcl-xS, through the alternative splicing of exon 2 in its pre-mRNA. These isoforms have antagonistic function in apoptotic pathway; Bcl-xL is pro-apoptotic, while Bcl-xS is anti-apoptotic. The balanced ratio of two isoforms is important for cell survival. However, regulatory mechanisms of Bcl-x splicing remain poorly understood. Using a mini-gene system, we have found that a 105 nt exonic region (E3b) located within exon 3 affects exon 2 splicing in the Bcl-x gene. Further deletion and mutagenesis studies demonstrate that this 105 nt sequence contains various functional elements which promote skipping of exon 2b. One of these elements forms a stem-loop structure that stimulates skipping of exon 2b. Furthermore our results prove that the stem-loop structure functions as an enhancer in general pre-mRNA splicing. We conclude that we have identified a cis-regulatory element in exon 3 that affects splicing of exon 2 in the Bcl-x gene. This element could be potentially targeted to alter the ratio of Bcl-xL and Bcl-xS for treatment of tumors through an apoptotic pathway.
Insights
Researchers identified a novel cis-regulatory element in the Bcl-x gene that controls alternative splicing. This finding could lead to new cancer treatments by modulating apoptosis via the Bcl-xL/Bcl-xS ratio.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Alternative splicing regulates apoptosis, with Bcl-x producing antagonistic isoforms: Bcl-xL (pro-apoptotic) and Bcl-xS (anti-apoptotic).
- A balanced Bcl-xL/Bcl-xS ratio is crucial for cell survival, but its regulation is not fully understood.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling alternative splicing of the Bcl-x gene.
- To identify specific cis-regulatory elements involved in Bcl-x pre-mRNA splicing.
Main Methods:
- Utilized a mini-gene system to study Bcl-x alternative splicing.
- Performed deletion and mutagenesis studies on a 105 nt exonic region (E3b) within exon 3.
Main Results:
- Identified a 105 nt exonic region (E3b) in Bcl-x exon 3 that influences exon 2 splicing.
- Discovered functional elements within E3b, including a stem-loop structure, that promote exon 2 skipping.
- Demonstrated that the stem-loop structure acts as a general pre-mRNA splicing enhancer.
Conclusions:
- Identified a novel cis-regulatory element in Bcl-x exon 3 that affects exon 2 splicing.
- This element, particularly the stem-loop structure, plays a key role in regulating the Bcl-xL/Bcl-xS ratio.
- Potential therapeutic target for cancer treatment by modulating apoptosis through altered Bcl-x isoform ratios.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Cis-regulatory Sequences
Cis-regulatory Sequences

